Cannabis Sativa (CBDS) 10-Q 15 Nov 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 14, 2016
Document and Entity Information:
Entity Registrant Name	Cannabis Sativa, Inc.
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Entity Central Index Key	1,360,442
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		18,474,673
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Entity Incorporation, Date of Incorporation	Nov. 5, 2004
Trading Symbol	cbds

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current Assets
Cash and Cash Equivalents	$ 75,899	$ 10,356
Digital Currency	41,240	5,203
Accounts Receivable, Net	14,290	4,190
Prepaids	465,893
Employee Advance	77	44
Inventories	28,890	24,937
Investment in Joint Venture	35,000	35,000
Total Current Assets	661,289	79,730
Property and Equipment, Net	16,634	4,504
Intangible Assets, Net	3,260,755	2,904,121
Investment	9,760	9,760
Due from Related Parties		248,182
Deposits	4,236	4,236
Note Receivable - Related Party	15,000
Total Assets	3,967,674	3,250,533
Current Liabilities:
Accounts Payable and Accrued Expenses	147,977	344,394
Due to Related Parties - Short Term	336,117	27,427
Total Liabilities	484,094	371,821
Stockholders' Equity:
Preferred stock $0.001 par value; 5,000,000 shares authorized; 732,018 and 428,585 issued and outstanding	732	429
Common stock $0.001 par value; 45,000,000 shares authorized; 18,474,673 and 17,374,738 shares issued and outstanding, respectively	18,475	17,375
Stock Subscriptions Payable		14,303
Additional Paid-In Capital	58,059,367	56,938,810
Accumulated Deficit	(54,937,604)	(54,093,099)
Total Cannabis Sativa, Inc. Stockholders' Equity	3,140,970	2,877,818
Non-Controlling Interest	342,610	894
Total Stockholders' Equity	3,483,580	2,878,712
Total Liabilities and Stockholders' Equity	$ 3,967,674	$ 3,250,533

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Statement of Financial Position
Common Stock, par or stated value	$ 0.001	$ 0.001
Common Stock, shares authorized	45,000,000	45,000,000
Common Stock, shares issued	18,474,673	17,374,738
Common Stock, shares outstanding	18,474,673	17,374,738
Preferred Stock, par or stated value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	5,000,000	5,000,000
Preferred Stock, shares issued	732,018	428,585
Preferred Stock, shares outstanding	732,018	428,585

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement
Revenues	$ 6,707	$ 6,378	$ 24,243	$ 8,096
Cost of Revenues	1,243	13,172	8,567	14,575
Gross Profit	5,464	(6,794)	15,676	(6,479)
General and Administrative Expenses	456,844	1,762,707	890,009	5,413,153
Loss from Operations	(451,380)	(1,769,501)	(874,333)	(5,419,632)
Other (Income) and Expenses
(Gain) Loss on Digital Currency Conversion	18,176		(30,105)
Interest Expense	1,798	9,571	7,164	26,635
Total Other (Income) and Expenses	19,974	9,571	(22,941)	26,635
Loss from Continuing Operations Before Discontinued Operations	(471,354)	(1,779,072)	(851,392)	(5,446,267)
Loss from Discontinued Operations		244		108,439
Loss Before Income Taxes	(471,354)	(1,779,316)	(851,392)	(5,554,706)
Income Taxes
Loss from Continuing Operations	(471,354)	(1,779,316)	(851,392)	(5,554,706)
Net Loss for the Period	(471,354)	(1,779,316)	(851,392)	(5,554,706)
Loss Attributable to Non-Controlling Interest	(6,887)		(6,887)
Net Loss Attributable To Cannabis Sativa, Inc.	$ (464,467)	$ (1,779,316)	$ (844,505)	$ (5,554,706)
Net Loss for the Period per Common Share:
Basic & Diluted Continuing Operations	$ (0.03)	$ (0.11)	$ (0.05)	$ (0.35)
Basic & Diluted Discontinued Operations		$ 0		$ (0.01)
Weighted Average Common Shares Outstanding:
Basic & Diluted	18,235,494	16,074,412	17,704,875	15,925,242

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss for the Period	$ (851,392)	$ (5,554,706)
Adjustments to Reconcile Net Loss for the Period to Net Cash Used in Operating Activities:
Depreciation and Amortization	39,231	90,053
Stock Issued for Services	1,570,124	3,215,655
Stock Returned - Legal Settlement	(479,558)
Contributed Capital		16,426
Amortization of Prepaid		1,813,041
Imputed Interest on Loans	3,509	9,316
Changes in assets and liabilities:
Digital Currency	(30,106)
Accounts Receivable	(10,100)	(5,818)
Inventories	(3,953)	501
Prepaids	(465,893)	(2,485)
Employeee Advances	(33)	(31)
Deposits		(3,205)
Accounts Payable and Accrued Expenses	59,416	141,164
Accrued Interest		1,655
Net Cash Used in Operating Activities:	(168,755)	(278,434)
Net Cash Used in Discontinued Activities:		6,840
Cash Flows from Investing Activities:
Purchase of Fixed Assets and Intangibles	(225)	(8,410)
Cash Acquired in Merger	4,238
Note Receivable - Related Party	(15,000)
Net Cash Used in Investing Activities:	(10,987)	(8,410)
Cash Flows from Financing Activities:
Payments to Related Parties	(6,015)	(40,345)
Proceeds from Related Parties	251,300	316,240
Net Cash Provided by Financing Activities:	245,285	275,895
NET CHANGE IN CASH AND CASH EQUIVALENTS	65,543	(4,109)
Cash and Cash Equivalents - Beginning of Period	10,356	25,994
Cash and Cash Equivalents - End of Period	75,899	21,885
Supplemental Disclosures of Non Cash Activities:
Contribution of Digital Currency	5,931
Conversion of Debt to Equity	255,834
Shares Issued for Accrued Liabilities	$ 15,000	362,250
Shares issued for Prepaid Items		3,246,925
Preferred Shares Issued for Related Party Payables		$ 3,747,668

1. Summary of Significant Accou

1. Summary of Significant Accounting Policies and Use of Estimates	9 Months Ended
	Sep. 30, 2016
Notes
1. Summary of Significant Accounting Policies and Use of Estimates:	1. Summary of Significant Accounting Policies and Use of Estimates: Presentation of Interim Information: The condensed consolidated financial statements included herein have been prepared by Cannabis Sativa, Inc., formerly named Ultra Sun Corp. ("we", "us", "our" or "Company"), without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC") and should be read in conjunction with the annual report on Form 10-k filed with the SEC May 6, 2016. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, as permitted by the SEC, although we believe the disclosures, which are made, are adequate to make the information presented not misleading. Further, the condensed financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at September 30, 2016, and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the period ended September 30, 2016 are not necessarily indicative of the results to be expected for the full year. Nature of Corporation: We were incorporated under the laws of Nevada in November 2004 as Ultra Sun Corp. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. Our wholly-owned subsidiary Kush was acquired by us in June 2014 in exchange for shares of our common stock. Our wholly-owned subsidiary Wild Earth Naturals, Inc. ("Wild Earth") was acquired by us in July 2013 in exchange for shares of our common stock. The acquisition of Kush resulted in a change of control of the Company and at or after the closing of the acquisition of Kush, the persons designated by Kush became the officers and directors of the Company. From our inception through September 30, 2013 we were engaged in the tanning salon business and operated a tanning salon in Saratoga Springs, Utah under the name "Sahara Sun Tanning." As a result of our acquisition of Wild Earth in July 2013, we became engaged in the herbal skin care products business. On September 30, 2013 we sold the assets of the tanning salon business to a third party. As a result of our acquisition of Kush in June 2014, along with our Wild Earth operations we are now engaged in the developing and promoting of natural cannabis products. On November 2, 2015, Kush was spun out of the Company. On August 8, 2016 the Company entered into a securities purchase agreement with iBudtender Inc. to purchase 50.1% of iBudtender Inc. Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Accounts Receivable: We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific impairment allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due. At September 30, 2016 the company has established an allowance for doubtful accounts of $-0-. Inventory: The Company calculates inventory using the average cost method to value inventory. Inventory cost includes those costs directly attributable to the product before sale. Fair Value of Financial Instruments: The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable, accrued liabilities, and notes payable approximate fair value given their short term nature or effective interest rates. Cash and Cash Equivalents: For financial accounting purposes, cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less. Earnings per Share: Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. As of September 30, 2016 and 2015, the Company has no outstanding potentially dilutive securities. Revenue Recognition: The Company recognizes revenue from product sales or services rendered when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Digital Currencies Translations and Re-measurements The Company accounts for digital currencies, which it considers to be an operating asset, at their initial cost and subsequently re-measures the carrying amounts of digital currencies it owns at each reporting date based on their current fair value. The changes in the fair value of digital currencies are included as a component of income or loss from operations. The Company currently classifies digital currencies as a current asset. The Company obtains the equivalency rate of hempcoins to bitcoins to USD from Coinmarketcap.com. The equivalency rate of garycoins to bitcoins to USD is obtained from C-cex.com and Coinmarketcap.com. The equivalency rate obtained from Coinmarket represents a generally well recognized quoted price in an active market for bitcoins, which market and related database are accessible to the Company on an ongoing basis. The Bitcoin Price Index was $605.64 as of September 30, 2016. Intangible Assets: Intangible assets are comprised of patents, trademarks, the Company's "CBDS.com" website domain and intellectual property rights. The patent is being amortized using the straight-line method over its economic life, which is estimated to be twenty (20) years. The trademark, which is still in the application phase, is expected to have an indefinite useful life. The CBDS.com website is expected to have an indefinite useful life. The intellectual property rights are being amortized using the straight-line month over its economic life, which is estimated to be (20) years. Income Taxes: The Company estimates the annual tax rate based on projected taxable income for the full year and records a quarterly income tax provision in accordance with the anticipated annual rate. As the year progresses, we refine the estimates of the year's taxable income as new information becomes available, including year-to-date financial results. This continual estimation process can result in a change to the expected effective tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in estimate occurs so that the year-to-date provision reflects the expected annual tax rate. Significant judgment may be required in determining the Company's effective tax rate and in evaluating our tax positions. The effective income tax rate of 0% for the periods ended September 30, 2016 and 2015 differed from the statutory rate, due primarily to net operating losses incurred by the Company in the respective periods. For the nine months ended September 30, 2016 a tax benefit of approximately $126,676 would have been generated. For the nine months ended September 30, 2015 a tax benefit of approximately $833,206 would have been generated. However, all benefits have been fully offset through an allowance account due to the uncertainty of the utilization of the net operating losses. As of September 30, 2016 the Company had net operating losses of approximately $844,505 resulting in a deferred tax asset of approximately $126,676. As of September 30, 2015 the Company had net operating losses of approximately $5,554,706 resulting in a deferred tax asset of approximately $833,206. The Company has established a valuation allowance in the full amount of the deferred tax asset due to the uncertainty of the utilization of operating losses in future periods. Pending Accounting Pronouncements: There have been no recent accounting pronouncements issued which are expected to have a material effect on the Company's financial statements.

2. Eden Holdings Llc

2. Eden Holdings Llc	9 Months Ended
	Sep. 30, 2016
Notes
2. Eden Holdings Llc	2. Eden Holdings LLC During the quarter ended September 30, 2014, the Company created Eden Holdings LLC. The purpose of the entity is to hold the intellectual property of Cannabis Sativa, Inc. As of September 30, 2016 there has been no activity in the LLC.

3. Fair Value Measurements

3. Fair Value Measurements	9 Months Ended
	Sep. 30, 2016
Notes
3. Fair Value Measurements	3. Fair Value Measurements We adopted ASC Topic 820 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts receivable, inventory, notes payable, accounts payable, accrued liabilities approximate fair value given their short term nature or effective interest rates. We measure certain financial instruments at fair value on a recurring basis. As of September 30, 2016, assets and liabilities measured at fair value on a recurring basis were as follows: Total Level 1 Level 2 Level 3 Assets: Digital Currency $41,240 $41,240 $- $- Total assets meassured at fair value $41,240 $41,240 $- $- Liabilities: $- $- $- $- Total liabilities measured at fair value $- $- $- $-

4. Hempcoins

4. Hempcoins	9 Months Ended
	Sep. 30, 2016
Notes
4. Hempcoins	4. Hempcoins At September 30, 2016, the Company has possession of 110,000,000 hempcoins. Hempcoins are reported as digital currency. Every 10 hempcoins are backed by 1 share of Rocky Mountain Inc (RMTN). At September 30, 2016 the value of hempcoins was $35,309 computed by converting first to bitcoin and then to US Dollars. (See Note 1).

5. Garycoins

5. Garycoins	9 Months Ended
	Sep. 30, 2016
Notes
5. Garycoins	5. Garycoins At September 30, 2016, the Company has possession of 450,002,549 garycoins. Garycoins are reported as digital currency. At September 30, 2016 the value of garycoins was $5,931 computed by converting to a bitcoin value in US Dollars. (See Note 1).

6. Related Parties

6. Related Parties	9 Months Ended
	Sep. 30, 2016
Notes
6. Related Parties	6. Related Parties During the nine months ended September 30, 2016 the Company received additional short-term advances from related parties and officers of the Company to cover operating expenses in the amount of $251,300. As of September 30, 2016, net advances to the Company were $336,117. The Company has imputed interest on these sums at the rate of 5% per annum and has recorded interest expense related to these balances in the amount of $3,509. Because the related parties do not expect the imputed interest to be repaid, the interest has been recorded as a contribution of capital during the nine months ended September 30, 2016. The Company also has a $15,000 note receivable from a related party. Payment is not expected currently.

7. Common Stock

7. Common Stock	9 Months Ended
	Sep. 30, 2016
Notes
7. Common Stock	7. Common Stock During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of 5,000 shares of its common stock to each of its seven (7) board of directors for their service through March 31, 2016. The Company recorded $31,388 in board of director fees on its statement of operations for the three months ended March 31, 2016. During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of common stock to a consultant for their service through March 31, 2016. The Company recorded $29,040 in consulting fees on its statement of operations for the three months ended March 31, 2016. As of March 31, 2016 the stock was yet to be issued. During the three months ended June 30, 2016 the Company's board of directors authorized the issuance of 50,000 shares of its common stock to a consultant for their services for the prior three months and the three months through June 30, 2016. The Company recorded $51,960 in consulting fees on its statement of operations for the three months ended June 30, 2016. During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of 50,000 shares of its common stock to two (2) board of directors and two (2) consultants for their service through March 31, 2016. The Company recorded $78,470 in professional fees on its statement of operations for the three months ended March 31, 2016. During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of 30,000 shares to a consultant for services to be provided during through March 31, 2016. The value of the issuance was determined to be $40,726. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 5,000 shares of its common stock to each of its seven (7) board of directors for their service through June 30, 2016. The Company recorded $80,612 in board of director fees on its statement of operations for the three months ended June 30, 2016. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 72,115 shares of its common stock to five (5) consultants of which three (3) are also members of the board of directors. The stock was issued for their services through June 30, 2016. The value of the issuance was determined to be $75,000. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 19,457 shares to a consultant for services that were provided during through June 30, 2016. The value of the issuance was determined to be $21,500. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 25,000 shares to a consultant for services that were provided during through June 30, 2016. The value of the issuance was determined to be $40,000. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 50,000 shares to two (2) consultants for services that were provided during through June 30, 2016. The value of the issuance was determined to be $160,000. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 30,000 shares in payment for a liability owed on the Company's joint venture agreement. The value of the issuance was determined to be $35,000. During the three months ended June 30, 2016, the Company's received 256,448 shares of their common stock as was required in their legal settlement. The value of the return was valued to be $479,558 and was offset against prior professional fees incurred. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 238,768 shares in payment for a liabilities owed by the Company in the amount of $220,833. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 400,000 shares of its common stock to five (5) consultants of which three (3) are also members of the board of directors. The stock was issued for their services through June 30, 2016. The value of the issuance was determined to be $630,500. During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 50,000 shares to a consultant, who is also on the board of directors, for services that were provided during through June 30, 2016. The value of the issuance was determined to be $116,500. During the three months ended September 30, 2016, the Company's board of directors authorized the issuance of 24,235 shares to 2 (two) consultants for services that were provided during through September 30, 2016. The value of the issuance was determined to be 42,850. During the three months ended September 30, 2016, the Company's board of directors authorized the issuance of 70,378 shares to 2 (two) attorneys of the Company for services that were provided during through September 30, 2016 and for services to be rendered through December 31, 2016. The value of the issuance was determined to be $125,524 with $60,279 expensed and $65,245 in prepaid expenses. During the three months ended September 30, 2016, the Company's board of directors authorized the issuance of 41,430 shares of its common stock to five (5) consultants of which three (3) are also members of the board of directors. The stock was issued for their services through September 30, 2016. The value of the issuance was determined to be $75,000. During the three months ended September 30, 2016, the Company's board of directors authorized the issuance of 100,000 shares to iBudtender Inc. pursuant to the purchase agreement. The value of the issuance was determined to be $200,000. During the three months ended September 30, 2016, the Company's board of directors authorized the issuance of 5,000 shares of its common stock to each of its seven (7) board of directors for their service through September 30, 2016. The Company recorded $62,475 in board of director fees on its statement of operations for the three months ended September 30, 2016.

8. Hi Brands International Inc.

8. Hi Brands International Inc. - Centuria Foods Agreement	9 Months Ended
	Sep. 30, 2016
Notes
8. Hi Brands International Inc. - Centuria Foods Agreement	8. Hi Brands International Inc. – Centuria Foods Agreement On February 6, 2015, the Company formed Hi Brands International Inc., a Nevada Corporation and wholly owned subsidiary of Cannabis Sativa, Inc. On February 25, 2015, the Company through its wholly owned subsidiary Hi Brands International, Inc. (jointly referred to hereinafter as "Cannabis Sativa"), entered into a Purchase, Supply and Joint Venture Agreement (the "Agreement"), with Centuria Natural Foods, Inc. ("Centuria") whereby Cannabis Sativa will market Centuria's proprietary CBD (Cannabidiol) Rich Hemp Oil products (the "Products"). The initial term of the Agreement is one year which may be renewed for additional one year periods upon the mutual agreement of the parties. Within the first 90 days of the initial term of the Agreement, Cannabis Sativa shall order at least 5,000 units of Product. Thereafter, Cannabis Sativa shall order at least 5,000 units of Product per month with the additional requirement that Cannabis Sativa order a minimum of 55,000 units of Product during the first 12 months of the Agreement. Fifty percent of all gross revenue generated by the sale of the Products will be paid to Cannabis Sativa and fifty percent will be paid to Centuria. As of September 30, 2016, there has not been any activity in Hi Brands International Inc. other than the execution of the above agreement. The Company has not ordered any product under this agreement as of September 30, 2016.

9. Purchase of Ibudtender Inc.

9. Purchase of Ibudtender Inc.	9 Months Ended
	Sep. 30, 2016
Notes
9. Purchase of Ibudtender Inc.	9. Purchase of iBudtender Inc. On August 8, 2016, the Company purchased 50.1 % interest in iBudtender Inc. The Company paid iBudtender $50,000 and issued iBudtender 150,000 shares of common stock, of which 100,000 were issued at closing and 50,000 are to be issued 180 days from closing. In exchange, iBudtender issued 5,010,000 shares of common stock to the Company. Since this was not a significant acquisition, the Company did not file an Amended 8K. The following was acquired and assumed from iBudtender at closing on August 8, 2016: Cash $5,635 Intellectual Property 407,770 Total Assets $413,405 Notes Payable – Related Parties (63,405) Net Purchase $350,000

10. Going Concern Consideration

10. Going Concern Considerations	9 Months Ended
	Sep. 30, 2016
Notes
10. Going Concern Considerations	10. Going Concern Considerations The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has incurred net losses since inception. As reported in the financial statements, the Company has an accumulated deficit which raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on its ability to raise adequate capital to fund operating losses until it is able to engage in profitable business operations. To the extent financing is not available, the Company may not be able to, or may be delayed in, developing its services and meeting its obligations. The Company will continue to evaluate its projected expenditures relative to its available cash and to evaluate additional means of financing in order to satisfy its working capital and other cash requirements. The accompanying financial statements do not reflect any adjustments that might result from the outcome of these uncertainties.

11. Other Matters

11. Other Matters	9 Months Ended
	Sep. 30, 2016
Notes
11. Other Matters	11. Other Matters The Company has also submitted its application to be listed on NASDAQ.

12. Subsequent Events

12. Subsequent Events	9 Months Ended
	Sep. 30, 2016
Notes
12. Subsequent Events	12. Subsequent Events The Company approved a Private Placement Memorandum on October 14, 2016. The total offering proceeds will be $1,500,000 by offering 625,000 of the Company's stock at $2.40 per share. Each unit will consist of 1 (one) share of common stock and 1 (one) warrant. Each warrant entitles the holder to purchase 1(one) common share at the exercise price of $4.00. The offering will terminate on December 14, 2016 but can be extended for up to 60 additional days.

1. Summary of Significant Acc18

1. Summary of Significant Accounting Policies and Use of Estimates (Policies)	9 Months Ended
	Sep. 30, 2016
Policies
Use of Estimates	Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Accounts Receivable	Accounts Receivable: We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific impairment allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due. At September 30, 2016 the company has established an allowance for doubtful accounts of $-0-.
Inventory	Inventory: The Company calculates inventory using the average cost method to value inventory. Inventory cost includes those costs directly attributable to the product before sale.
Fair Value of Financial Instruments:	Fair Value of Financial Instruments: The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable, accrued liabilities, and notes payable approximate fair value given their short term nature or effective interest rates.
Cash and Cash Equivalents	Cash and Cash Equivalents: For financial accounting purposes, cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less.
Earnings Per Share:	Earnings per Share: Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. As of September 30, 2016 and 2015, the Company has no outstanding potentially dilutive securities.
Revenue Recognition:	Revenue Recognition: The Company recognizes revenue from product sales or services rendered when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured.
Digital Currencies Translations and Re-measurements	Digital Currencies Translations and Re-measurements The Company accounts for digital currencies, which it considers to be an operating asset, at their initial cost and subsequently re-measures the carrying amounts of digital currencies it owns at each reporting date based on their current fair value. The changes in the fair value of digital currencies are included as a component of income or loss from operations. The Company currently classifies digital currencies as a current asset. The Company obtains the equivalency rate of hempcoins to bitcoins to USD from Coinmarketcap.com. The equivalency rate of garycoins to bitcoins to USD is obtained from C-cex.com and Coinmarketcap.com. The equivalency rate obtained from Coinmarket represents a generally well recognized quoted price in an active market for bitcoins, which market and related database are accessible to the Company on an ongoing basis. The Bitcoin Price Index was $605.64 as of September 30, 2016.
Intangible Assets:	Intangible Assets: Intangible assets are comprised of patents, trademarks, the Company's "CBDS.com" website domain and intellectual property rights. The patent is being amortized using the straight-line method over its economic life, which is estimated to be twenty (20) years. The trademark, which is still in the application phase, is expected to have an indefinite useful life. The CBDS.com website is expected to have an indefinite useful life. The intellectual property rights are being amortized using the straight-line month over its economic life, which is estimated to be (20) years.
Income Taxes:	Income Taxes: The Company estimates the annual tax rate based on projected taxable income for the full year and records a quarterly income tax provision in accordance with the anticipated annual rate. As the year progresses, we refine the estimates of the year's taxable income as new information becomes available, including year-to-date financial results. This continual estimation process can result in a change to the expected effective tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in estimate occurs so that the year-to-date provision reflects the expected annual tax rate. Significant judgment may be required in determining the Company's effective tax rate and in evaluating our tax positions. The effective income tax rate of 0% for the periods ended September 30, 2016 and 2015 differed from the statutory rate, due primarily to net operating losses incurred by the Company in the respective periods. For the nine months ended September 30, 2016 a tax benefit of approximately $126,676 would have been generated. For the nine months ended September 30, 2015 a tax benefit of approximately $833,206 would have been generated. However, all benefits have been fully offset through an allowance account due to the uncertainty of the utilization of the net operating losses. As of September 30, 2016 the Company had net operating losses of approximately $844,505 resulting in a deferred tax asset of approximately $126,676. As of September 30, 2015 the Company had net operating losses of approximately $5,554,706 resulting in a deferred tax asset of approximately $833,206. The Company has established a valuation allowance in the full amount of the deferred tax asset due to the uncertainty of the utilization of operating losses in future periods.
Pending Accounting Pronouncements:	Pending Accounting Pronouncements: There have been no recent accounting pronouncements issued which are expected to have a material effect on the Company's financial statements.

3. Fair Value Measurements_ Sch

3. Fair Value Measurements: Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Tables)	9 Months Ended
	Sep. 30, 2016
Tables/Schedules
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	As of September 30, 2016, assets and liabilities measured at fair value on a recurring basis were as follows: Total Level 1 Level 2 Level 3 Assets: Digital Currency $41,240 $41,240 $- $- Total assets meassured at fair value $41,240 $41,240 $- $- Liabilities: $- $- $- $- Total liabilities measured at fair value $- $- $- $-

9. Purchase of Ibudtender Inc._

9. Purchase of Ibudtender Inc.: Schedule of iBudtender Assets Acquired and Liabilities Assumed (Tables)	9 Months Ended
	Sep. 30, 2016
Tables/Schedules
Schedule of iBudtender Assets Acquired and Liabilities Assumed	Cash $5,635 Intellectual Property 407,770 Total Assets $413,405 Notes Payable – Related Parties (63,405) Net Purchase $350,000

1. Summary of Significant Acc21

1. Summary of Significant Accounting Policies and Use of Estimates (Details)	Jun. 01, 2014	Sep. 30, 2016	Aug. 08, 2016
Entity Incorporation, Date of Incorporation		Nov. 5, 2004
iBudtender, Inc.
Equity Method Investment, Ownership Percentage			50.10%
Kush
Acquired date	Jun. 1, 2014
Spin-off date		Nov. 2, 2015

1. Summary of Significant Acc22

1. Summary of Significant Accounting Policies and Use of Estimates: Accounts Receivable (Details)	9 Months Ended
	Sep. 30, 2016USD ($)
Details
Allowance for doubtful accounts	$ 0

1. Summary of Significant Acc23

1. Summary of Significant Accounting Policies and Use of Estimates: Earnings Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Details
Potentially dilutive securities outstanding	0	0

1. Summary of Significant Acc24

1. Summary of Significant Accounting Policies and Use of Estimates: Digital Currencies Translations and Re-measurements (Details)	Sep. 30, 2016USD ($)
Details
Bitcoin Price Index	$ 605.64

1. Summary of Significant Acc25

1. Summary of Significant Accounting Policies and Use of Estimates: Intangible Assets (Details)	9 Months Ended
	Sep. 30, 2016
Patent
Finite-Lived Intangible Asset, Useful Life	20 years
Intellectual Property
Finite-Lived Intangible Asset, Useful Life	20 years

1. Summary of Significant Acc26

1. Summary of Significant Accounting Policies and Use of Estimates: Income Taxes (Details) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Details
Effective Income Tax Rate Reconciliation, Percent	0.00%	0.00%
Federal Tax Benefit (Expense) at Statutory Rates	$ 126,676	$ 833,206
Operating Loss Carryforwards	844,505	5,554,706
Deferred Tax Assets	$ 126,676	$ 833,206

3. Fair Value Measurements_ S27

3. Fair Value Measurements: Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)	Sep. 30, 2016USD ($)
Assets:
Digital Currency	$ 41,240
Total assets measured at fair value	41,240
Total liabilities measured at fair value	0
Fair Value, Inputs, Level 1
Assets:
Digital Currency	41,240
Total assets measured at fair value	41,240
Total liabilities measured at fair value	0
Fair Value, Inputs, Level 2
Assets:
Digital Currency	0
Total assets measured at fair value	0
Total liabilities measured at fair value	0
Fair Value, Inputs, Level 3
Assets:
Digital Currency	0
Total assets measured at fair value	0
Total liabilities measured at fair value	$ 0

4. Hempcoins (Details)

4. Hempcoins (Details)	Sep. 30, 2016USD ($)
Number of hempcoins held	110,000,000
Investment Owned, Fair Value	$ 41,240
Hempcoins
Investment Owned, Fair Value	$ 35,309

5. Garycoins (Details)

5. Garycoins (Details)	Sep. 30, 2016USD ($)
Number of Garycoins held	450,002,549
Investment Owned, Fair Value	$ 41,240
Garycoins
Investment Owned, Fair Value	$ 5,931

6. Related Parties (Details)

6. Related Parties (Details) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Details
Proceeds from Related Parties	$ 251,300	$ 316,240
Due to Related Parties - Short Term	$ 336,117		$ 27,427
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Imputed Interest on Loans	$ 3,509	$ 9,316
Note Receivable - Related Party	$ 15,000

7. Common Stock (Details)

7. Common Stock (Details) - USD ($)	3 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016
Stock issued in payment for a liability, value		$ 220,833
Stock returned to the company, value		479,558
Prepaids	$ 465,893
Consultants
Consulting expense		51,960	$ 29,040
Consultants 2
Shares issued for services, Value		21,500	$ 40,726
Consultants 3
Shares issued for services, Value		40,000
Consultants 4
Shares issued for services, Value		160,000
Corporate Joint Venture
Stock issued in payment for a liability, value		$ 35,000
iBudtender, Inc.
Stock Issued During Period, Shares, Acquisitions	150,000
Common Stock
Stock issued in payment for a liability, shares		238,768
Stock returned to the company, shares		256,448
Common Stock | Consultants
Shares issued for services, Shares	24,235		50,000
Shares issued for services, Value	$ 42,850
Common Stock | Consultants 2
Shares issued for services, Shares		19,457	30,000
Common Stock | Consultants 3
Shares issued for services, Shares		25,000
Common Stock | Consultants 4
Shares issued for services, Shares		50,000
Common Stock | Corporate Joint Venture
Stock issued in payment for a liability, shares		30,000
Common Stock | Attorneys
Shares issued for services, Shares	70,378
Allocated Share-based Compensation Expense	$ 60,279
Shares issued for services, Value	125,524
Prepaids	$ 65,245
Common Stock | iBudtender, Inc.
Stock Issued During Period, Shares, Acquisitions	100,000
Stock Issued During Period, Value, Acquisitions	$ 200,000
Director
Allocated Share-based Compensation Expense		$ 80,612	$ 31,388
Director | Consultants
Professional Fees			$ 78,470
Shares issued for services, Value		75,000
Director | Consultants 5
Shares issued for services, Value		630,500
Director | Consultants 6
Shares issued for services, Value		$ 116,500
Director | Common Stock
Shares issued for services, Shares	5,000	5,000	5,000
Shares issued for services, Value	$ 62,475
Director | Common Stock | Consultants
Shares issued for services, Shares		72,115	50,000
Director | Common Stock | Consultants 2
Shares issued for services, Shares	41,430
Shares issued for services, Value	$ 75,000
Director | Common Stock | Consultants 5
Shares issued for services, Shares		400,000
Director | Common Stock | Consultants 6
Shares issued for services, Shares		50,000

8. Hi Brands International In32

8. Hi Brands International Inc. - Centuria Foods Agreement (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)
Revenues	$ 6,707	$ 6,378	$ 24,243	$ 8,096
Centuria Natural Foods, Inc.
Minimum Product Order Size, per month			5,000
Minimum Product Order Size			55,000
Revenues			$ 0

9. Purchase of Ibudtender Inc.

9. Purchase of Ibudtender Inc. (Details) - iBudtender, Inc. - USD ($)	3 Months Ended
	Sep. 30, 2016	Aug. 08, 2016
Equity Method Investment, Ownership Percentage		50.10%
Payments to Acquire Businesses, Gross	$ 50,000
Stock Issued During Period, Shares, Acquisitions	150,000
Purchase Description	100,000 were issued at closing and 50,000 are to be issued 180 days from closing
Investment Owned, Balance, Shares		5,010,000

9. Purchase of Ibudtender Inc34

9. Purchase of Ibudtender Inc.: Schedule of iBudtender Assets Acquired and Liabilities Assumed (Details) - iBudtender, Inc.	9 Months Ended
	Sep. 30, 2016USD ($)
Cash	$ 5,635
Intellectual Property	407,770
Total Assets	413,405
Notes Payable - Related Parties	(63,405)
Net Purchase	$ 350,000

12. Subsequent Events (Details)

12. Subsequent Events (Details)	9 Months Ended
	Sep. 30, 2016
Subsequent Event
Private Placement Offering Terms	The Company approved a Private Placement Memorandum on October 14, 2016. The total offering proceeds will be $1,500,000 by offering 625,000 of the Company's stock at $2.40 per share. Each unit will consist of 1 (one) share of common stock and 1 (one) warrant. Each warrant entitles the holder to purchase 1(one) common share at the exercise price of $4.00. The offering will terminate on December 14, 2016 but can be extended for up to 60 additional days.